Docoh
Loading...

11 results

Filter options loading...
Top filers
Top filing types
Recent filing years
10-K
2020 FY
PCSA Processa Pharmaceuticals Inc
24 Mar 21
Annual report
8:00pm
, transparency laws, government price reporting, and health information privacy and security laws. These laws include the following: the federal Anti-Kickback … , simplifying adverse-event reporting procedures, improving the supervision of clinical trials and increasing their transparency. Recently enacted
424B4
PCSA Processa Pharmaceuticals Inc
5 Oct 20
Prospectus supplement with pricing info
4:16pm
fraud and abuse laws, false claims laws, transparency laws, government price reporting, and health information privacy and security laws. These laws … their transparency. Recently enacted Clinical Trials Regulation EU No 536/2014 ensures that the rules for conducting clinical trials in the EU will be identical
S-1/A
PCSA Processa Pharmaceuticals Inc
30 Sep 20
IPO registration (amended)
4:06pm
and scientific and educational programs also must comply with state and federal fraud and abuse laws, false claims laws, transparency laws, government price … , improving the supervision of clinical trials and increasing their transparency. Recently enacted Clinical Trials Regulation EU No 536/2014 ensures
S-1/A
PCSA Processa Pharmaceuticals Inc
16 Sep 20
IPO registration (amended)
8:00pm
and scientific and educational programs also must comply with state and federal fraud and abuse laws, false claims laws, transparency laws, government price … , improving the supervision of clinical trials and increasing their transparency. Recently enacted Clinical Trials Regulation EU No 536/2014 ensures
S-1/A
PCSA Processa Pharmaceuticals Inc
17 Jul 20
IPO registration (amended)
5:25pm
laws, false claims laws, transparency laws, government price reporting, and health information privacy and security laws. These laws include … -trial authorization, simplifying adverse-event reporting procedures, improving the supervision of clinical trials and increasing their transparency
10-K
gka7mgb6 4sf5z25a3
5 Mar 20
Annual report
7:00pm
S-1
4dtq8m 9kj
13 Dec 19
IPO registration
5:32pm
10-Q
9sxvoy9p 693zd4f8n
14 Nov 19
Quarterly report
11:45am
10-Q
alfa2496i5bmrs
13 Aug 19
Quarterly report
8:00pm
10-Q
rrdoo 81wm7migvw0
14 May 19
Quarterly report
1:08pm
8-K
EX-99.1
9sqknq30ah72z8
6 Dec 18
Processa Pharmaceuticals Announces Up-listing to Otcqb Market
9:00am
  • 1